Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Oropharynx”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00928161
What this trial is testing

Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy

Who this might be right for
Head and Neck CancerOropharyngeal CancerGastroesophageal Reflux Disease
M.D. Anderson Cancer Center
Not applicableStudy completedNCT03890783
What this trial is testing

Functional Results of Soft Palate Free Flap Reconstruction

Who this might be right for
Oropharyngeal CancerPalate Free Flap Reconstruction
Hospices Civils de Lyon 29
Testing effectiveness (Phase 2)UnknownNCT00625937
What this trial is testing

Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Yonsei University 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05232851
What this trial is testing

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related CarcinomaLocally Advanced Oropharyngeal Carcinoma+2 more
Mayo Clinic 20
Not applicableLooking for participantsNCT03545256
What this trial is testing

Sentinel. Ambulatory. Oral Cavity. Oropharynx (S.A.C.O)

Who this might be right for
Cancer T1-N0 or T2-N0 of the Oral Cavity
University Hospital, Montpellier 25
Not applicableUnknownNCT04742998
What this trial is testing

Task of Acoustic-phonetic Decoding on Anatomic Deficits in Paramedical Assessment of Speech Disorders for Patients Treated for Oral or Oropharyngeal Cancer

Who this might be right for
Speech Intelligibility
University Hospital, Toulouse 116
Not applicableStudy completedNCT02262247
What this trial is testing

A Post-Market Clinical Trial for Access and Visualization of the Oropharynx, Hypopharynx and Larynx During Transoral Procedures

Who this might be right for
OSAOral DiseaseOropharyngeal Neoplasms+1 more
Medrobotics Corporation 80
Testing effectiveness (Phase 2)WithdrawnNCT01953952
What this trial is testing

Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer

Who this might be right for
Stage III Squamous Cell Carcinoma of the OropharynxStage IVA Squamous Cell Carcinoma of the OropharynxTongue Cancer
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT05098119
What this trial is testing

Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)

Who this might be right for
Oral Cavity Squamous Cell CarcinomaOral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06578871
What this trial is testing

Surgery and Reducing Ionizing Radiation of the Unknown Primary

Who this might be right for
Head and Neck Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 90
Testing effectiveness (Phase 2)Ended earlyNCT00003777
What this trial is testing

Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Abramson Cancer Center at Penn Medicine 35
Large-scale testing (Phase 3)Study completedNCT00094081
What this trial is testing

Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Sanofi 861
Testing effectiveness (Phase 2)Ended earlyNCT03601507
What this trial is testing

Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer

Who this might be right for
CDKN2A-p16 PositiveHPV Positive Oropharyngeal Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell Carcinoma AJCC V7+3 more
University of Arizona 9
Testing effectiveness (Phase 2)Looking for participantsNCT03215719
What this trial is testing

Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma

Who this might be right for
Oropharyngeal CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
NYU Langone Health 120
Testing effectiveness (Phase 2)Study completedNCT03623646
What this trial is testing

Cisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial.

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
Institut Claudius Regaud 11
Not applicableUnknownNCT05393297
What this trial is testing

InGReS: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study

Who this might be right for
Head and Neck Cancer
Guy's and St Thomas' NHS Foundation Trust 15
Testing effectiveness (Phase 2)Study completedNCT00084682
What this trial is testing

Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Stage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the LarynxStage IV Squamous Cell Carcinoma of the Lip and Oral Cavity+1 more
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Looking for participantsNCT04900623
What this trial is testing

Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

Who this might be right for
HPV-Associated Oropharyngeal Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell CarcinomaHPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Stage+9 more
Jonathan Schoenfeld, MD, MPH 145
Testing effectiveness (Phase 2)Study completedNCT01084083
What this trial is testing

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

Who this might be right for
Head and Neck CancerPrecancerous Condition
Eastern Cooperative Oncology Group 90
Testing effectiveness (Phase 2)Study completedNCT00006051
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
UNICANCER
Next Page